InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49
United States Fiscal year ends December CIK 0001422143
$10.60 +0.76% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $10.60 −43.10% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Net income−27.6Fiscal year 2017Net income−35.4Fiscal year 2018Net income−60.4Fiscal year 2019Net income−63.1Fiscal year 2020Net income−89.6EPS, diluted−1.69Fiscal year 2021Net income−130.5EPS, diluted−1.97Fiscal year 2022Operating income−139.9Net income−135.8EPS, diluted−2.03Fiscal year 2023Revenue0.0Operating income−165.8Net income−152.6EPS, diluted−2.08Fiscal year 2024Revenue53.9Operating income−193.2Net income−174.0EPS, diluted−2.02Fiscal year 2025Revenue67.5 +25.2%Operating income−303.6Net income−278.7EPS, diluted−3.18
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a n/a n/a n/a 0.0 53.9 67.5
Growth +25.2%
Operating income n/a n/a n/a n/a n/a n/a −139.9 −165.8 −193.2 −303.6
Net income −27.6 −35.4 −60.4 −63.1 −89.6 −130.5 −135.8 −152.6 −174.0 −278.7
Growth
EPS, diluted n/a n/a n/a n/a −1.69 −1.97 −2.03 −2.08 −2.02 −3.18
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Operating margin−358.5%Net margin−322.9%Free cash flow margin248.4%Fiscal year 2025Operating margin−449.9%Net margin−412.9%Free cash flow margin−104.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a n/a n/a n/a −358.5% −449.9%
Net margin n/a n/a n/a n/a n/a n/a n/a n/a −322.9% −412.9%
Free cash flow margin n/a n/a n/a n/a n/a n/a n/a n/a 248.4% −104.8%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−25.3Fiscal year 2017Operating cash flow−28.4Fiscal year 2018Operating cash flow−48.7Fiscal year 2019Operating cash flow−54.8Fiscal year 2020Operating cash flow−69.8Capital expenditure−2.2Free cash flow−72.0Fiscal year 2021Operating cash flow−104.6Capital expenditure−1.1Free cash flow−105.7Fiscal year 2022Operating cash flow−110.1Capital expenditure−0.6Free cash flow−110.7Fiscal year 2023Operating cash flow−124.8Capital expenditure−0.2Free cash flow−125.0Fiscal year 2024Operating cash flow134.3Capital expenditure−0.5Free cash flow133.8Fiscal year 2025Operating cash flow−64.1Capital expenditure−6.6Free cash flow−70.7 −152.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −25.3 −28.4 −48.7 −54.8 −69.8 −104.6 −110.1 −124.8 134.3 −64.1
Capital expenditure n/a n/a n/a n/a −2.2 −1.1 −0.6 −0.2 −0.5 −6.6
Free cash flow n/a n/a n/a n/a −72.0 −105.7 −110.7 −125.0 133.8 −70.7
Growth −152.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash9.7Total debt7.3Net cash (debt)2.4Shareholders’ equity56.9Debt to equity0.13Fiscal year 2017Cash11.4Total debt7.1Net cash (debt)4.3Shareholders’ equity79.9Debt to equity0.09Fiscal year 2018Cash16.1Total debt7.5Net cash (debt)8.6Shareholders’ equity161.0Debt to equity0.05Fiscal year 2019Cash26.1Total debt7.5Net cash (debt)18.6Shareholders’ equity218.8Debt to equity0.03Fiscal year 2020Cash325.5Total debt7.3Net cash (debt)318.2Shareholders’ equity610.9Debt to equity0.01Fiscal year 2021Cash90.7Shareholders’ equity506.6Fiscal year 2022Cash51.8Total debt9.2Net cash (debt)42.6Shareholders’ equity420.3Debt to equity0.02Fiscal year 2023Cash37.3Total debt9.3Net cash (debt)28.0Shareholders’ equity397.3Debt to equity0.02Fiscal year 2024Cash224.5Total debt9.5Net cash (debt)214.9Shareholders’ equity413.6Debt to equity0.02Fiscal year 2025Cash149.1Total debt9.7Net cash (debt)139.4Shareholders’ equity174.1Debt to equity0.06
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 9.7 11.4 16.1 26.1 325.5 90.7 51.8 37.3 224.5 149.1
Total debt 7.3 7.1 7.5 7.5 7.3 n/a 9.2 9.3 9.5 9.7
Net cash (debt) 2.4 4.3 8.6 18.6 318.2 n/a 42.6 28.0 214.9 139.4
Shareholders’ equity 56.9 79.9 161.0 218.8 610.9 506.6 420.3 397.3 413.6 174.1
Debt to equity 0.13 0.09 0.05 0.03 0.01 n/a 0.02 0.02 0.02 0.06

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a n/a n/a n/a n/a n/a n/a −358.5% −449.9%
n/a n/a n/a n/a n/a n/a n/a n/a −319.1% −412.5%
n/a n/a n/a n/a n/a n/a n/a n/a −322.9% −412.9%
n/a n/a n/a n/a n/a n/a n/a n/a 248.4% −104.8%
Spending
n/a n/a n/a n/a n/a n/a n/a n/a 315.4% 372.1%
n/a n/a n/a n/a n/a n/a n/a n/a 143.1% 177.8%
n/a n/a n/a n/a n/a n/a n/a n/a 0.9% 9.8%
Returns
−48.5% −44.4% −37.5% −28.9% −14.7% −25.8% −32.3% −38.4% −42.1% −160.0%
−39.5% −37.0% −33.1% −26.1% −13.8% −24.4% −29.8% −34.0% −22.9% −37.7%
Balance and payout
0.13 0.09 0.05 0.03 0.01 n/a 0.02 0.02 0.02 0.06
18.5% 16.7% 11.7% 9.6% 5.6% 5.1% 7.9% 11.5% 45.6% 76.4%